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1. Introduction
Mycobacterium tuberculosis, the causative agent of 
pulmonary tuberculosis (TB), infects one-third of the 
world’s population (Murray et al 1990). Despite the 
multiplicity of antimicrobial mechanisms mounted by its 
host, M. tuberculosis shows a remarkable ability to survive 
either by evoking survival strategies or by interfering 
with critical macrophage functions that are required to 
successfully respond to infection (Gehring et al 2004; Wang 
et al 2005; Pai et al 2003). M. tuberculosis has a unique 
ability to persist within the host in a latent state and undergo 
reactivation years later if the host’s immune system weakens 
(Deretic and Fratti 1999; Manabe and Bishai 2000). In fact, 
at this stage, the pathogen is diffi cult to target. Many studies 
have suggested that pathogenic mycobacteria primarily 
subsist on fatty acid substrates during infection and that fatty 
acids may be the primary source of energy during latency 
(Daniel et al 2004). In this respect, the bacilli’s lipases
can play an important role in the release and utilization of host 
fatty acids. Among the various lipases, phospholipases play 
an important role as virulence factors in a variety of bacterial 
infections. They are generally classifi ed into phospholipases 
A1, A2, C and D based on the cleavage position of the 
glycerol backbone in the phospholipids (Songer 1997). 
Among these groups, phospholipase C plays a signifi cant 
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part in the pathogenesis of a variety of bacteria (McNamara 
et al 1994; Songer 1997) as it generates a signalling lipid 
molecule sn-1,2-diacylglycerol (DAG), a protein kinase C 
activator in macrophages and other cell types. In addition, 
DAG is an activator of sphingomyelinase which leads 
to increased amounts of an important effector molecule, 
ceramide, which in turn activates MEK (mitogen-activated 
protein
 
kinase/extra cellular signal-regulated kinase kinase) 
through protein kinase C leading to subsequent extracellular 
signal-regulated kinases (ERK) activation (Monick et 
al 1999; Cuschieri et al 2006). Activation of the above-
mentioned mitogen-activated protein kinases represents an 
important signalling event that regulates the secretion of a 
variety of cytokines and chemokines by macrophages. In 
this regard, it has been reported that the growth of a triple 
plcABC mutant of M. tuberculosis was attenuated during the 
late phase of infection in mice (Raynaud et al 2002).
Earlier studies have reported that the promoter for Rv3487c 
was upregulated at a low pH and M. tuberculosis strains 
defi cient in Rv3487c exhibited an attenuated phenotype
in the lung of mice in comparison with virulent strains 
(Saviola et al 2003; Camacho et al 1999). Recently, it
was reported that Rv3487c (LipF) is a lipase with 
carboxyesterase activity (Zhang et al 2005). In this 
study, we demonstrate that Rv3487c possesses additional 
phospholipase C activity and localizes to the cell wall 
of M. tuberculosis. During infection due to tubercle 
bacilli, Rv3487c elicits clinical stage-specifi c humoral 
immunoreactivity with sera from children with tuberculosis, 
but not with sera from adult patients. 
2. Materials and methods
2.1 Cells and reagents
Cloning vector pGEMT Easy was purchased from Promega, 
USA. DNA-modifying enzymes, including restriction 
endonucleases, polymerases and ligase were procured 
from Fermentas, USA. Ni-NTA His binding resin, protein 
purifi cation column and gel extraction kit were from Qiagen. 
Middlebrook 7H9 was obtained from Difco, USA. Cell 
wall, cytosol, whole cell lysate and culture fi ltrate protein 
fractions of virulent M. tuberculosis were obtained from TB 
research materials and vaccine testing contract, Colorado 
State University, USA. Most chemicals were obtained 
from Sigma Aldrich except when otherwise specifi ed. 
(9, 10-
3
H (N)) triolein (10 Ci/mmol), [dipalmitoyl-1-
14
C]phosphatidylcholine (54 mCi/mmol) and [2-palmitoyl-
9,10-
3
H]phosphatidylcholine (92.3 Ci/mmol) were 
obtained from Perkin Elmer Biosystems. Phospholipase C 
from Bacillus cereus was obtained from Sigma Chemical 
Company, USA. Thin-layer chromatography (TLC) plates 
(Silica Gel 60 F-254) were from Merck, USA. 
2.2 Bacterial strains and culture conditions
For cloning and expression experiments, E. coli JM109, 
DH5α, and BL21(DE3)/pLysS (Novagen) were used as 
host strains and cultured in Luria Bertani broth or agar, 
as required, at 37°C, supplemented with 100 µg ml–1 
ampicillin. Mycobacterium smegmatis strain mc2155 was 
grown in Middlebrook 7H9 at 37°C, supplemented with 
0.05% Tween 80 (v/v), 0.2% glycerol (v/v). 
2.3 Synthesis of phospholipids
[
32
P]Phospholipids were biosynthesized from mung bean 
(Vigna radiate) by in vivo labelling with [32P]orthophosphate 
(Herman and Chrispeel 1980). Briefl y, 5 g of mung been 
seeds were soaked in distilled water for 2–3 h and then 
germinated on damp wet cotton in the presence of 20 µCi 
of [
32
P]orthophosphate for 2 days. The incorporation of 
[
32
P]orthophosphate was stopped by washing the seeds in 
cold water followed by boiling the seeds in 10% acetic 
acid in isopropyl alcohol. The seeds were then ground in 
a mortar and pestle and lipids were extracted according to 
the described protocol (Gangar et al 2002). A fraction of the 
extracted lipids in chloroform was applied on TLC plates 
and separated using chloroform:methanol:acetone:acetic 
acid:water (50:10:20:15:5, v/v). The region of the TLC 
plate corresponding to standard spots, phosphatidylcholine, 
phosphatidylethanolamine and phosphatidic acids were 
scraped independently and lipids were extracted from the 
silica. The incorporation of radioactivity was measured 
using a scintillation counter. Phospholipids were quantifi ed 
by digesting the organic phosphate with perchloric acid and 
the digested phosphate was determined colorimetrically. 
2.4 Thin-layer chromatography
Phospholipids were chromatographed twice by silica–TLC in 
the same direction with petroleum ether (30–60ºC):anhydrous 
acetone (1:3, v/v) followed by chloroform:methanol:ammonia 
(65:35:2.5, v/v). Neutral lipids were chromatographed with 
diethyl ether:petroleum ether (30–60ºC):glacial acetic acid 
(80:30:1, v/v). Silica–TLC plates (Merck, USA) were used 
in both chromatography systems. Lipids were routinely 
located by iodine vapour staining and, on occasion, by 
contact autoradiography with a Kodak X-ray fi lm. Lipids 
were identifi ed by comparing them with authentic standards 
obtained from commercial sources. All substrates were found 
to be chemically pure by these methods.
2.5 Cloning and expression of Rv3487c
The coding sequence of Rv3487c was amplifi ed by 
polymerase chain reaction (PCR) and cloned into the 
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pGEMT Easy vector from the BAC clone containing 
genomic DNA of M. tuberculosis with forward primer 
containing fl ag epitope 5′-gcggatccatggactacaaagacgatgacg
acaagcttgtlgcgtgcgcctggggtgcg-3′ and reverse primer 5′-gctc
tagagataggcgactgtccaaacg-3′. After DNA sequence analysis, 
the Rv3487c open reading frame (ORF) was subcloned into 
the expression vector pRSET-A. The E. coli BL21 strain 
carrying recombinant plasmids was induced with isopropyl β-
D-1-thiogalactopyranoside (IPTG) at 0.5 OD. Recombinant 
histidine–fl ag-tagged Rv3487c protein was expressed 
and purifi ed under denaturing conditions with an Ni-NTA 
column (Qiagen, USA). The purifi ed denatured protein was 
refolded by slow and step-wise dialysis. All lipase assays 
were performed using the fi nal purifi ed refolded protein. In 
addition, for the expression of Rv3487c in M. smegmatis, 
Rv3487c was released from pGEMT-Rv3487c as a BamH1-
Xba1 fragment and subcloned into the expression vector 
pJAM2, which utilizes the highly inducible acetamidase 
promoter of M. smegmatis (Triccas et al 1998).
2.6 Generation of polyclonal antiserum to Rv3487c
Eight-week-old rabbits were immunized with purifi ed 
Rv3487c protein with Freund incomplete adjuvant to raise 
rabbit polyclonal antibodies. The primary subcutaneous 
immunization was with 1 mg/ml of purifi ed Rv3487c protein 
in Freund incomplete adjuvant and, after a period of 30 
days, a booster dose of Rv3487c protein (1 mg/ml in Freund 
incomplete adjuvant) was given. After another 15 days, a 
second booster of Rv3487c (1 mg/ml) was given prior to the 
collection of rabbit antiserum.
2.7 Construction of recombinant M. smegmatis express-
ing Rv3487c and subcellular localization of Rv3487c
In order to express Rv3487c in M. smegmatis, the pJAM2–
Rv3487c construct was electroporated into M. smegmatis 
mc
2
155 strain and the recombinant Rv3487c protein was 
induced with 2% acetamide for 24 h at 37°C. The expression 
level of Rv3487c was confi rmed by SDS-PAGE and by 
immunoblotting with rabbit polyclonal antiserum. In order to 
detect the subcellular localization of Rv3487c, recombinant 
M. smegmatis expressing Rv3487c was harvested after 
acetamide induction and was resuspended in breaking buffer 
(2% v/v Triton X-100 in phosphate buffered saline [PBS]) 
at 0.5 gl
–1
 of wet weight. Cells were lysed by ultrasonication 
(10 × of a 60 s cycle with 2 min cooling period between each 
burst). Unbroken cells were removed by centrifuging at 6000 
g for 5 min and the cell lysate was centrifuged at 27 000 g at 
4°C for 30 min. In addition, the supernatant was subjected 
to an ultracentrifugation step at 100 000 g to separate the 
contaminating membranes and the supernatant obtained 
after this step was used as the cytosolic fraction. To further 
remove cytosolic contaminants, the pellet was incubated 
overnight in breaking buffer. Finally, the washed insoluble 
cell wall material was obtained by centrifuging at 27 000 g
at 4°C. Silver staining and western blot analysis were 
performed to identify the cellular localization of this protein 
by using these cellular fractions. To detect the presence of 
Rv3487c protein, 5 µg of different cellular fractions were 
further subjected to western blot analysis. We utilized a 
control antibody, a rabbit polyclonal antibody reactive to 
another mycobacterial antigen, in our studies and the results 
clearly demonstrated the absence of cross-reactivity with 
Rv3487c (data not shown).
2.8 Substrate preparation
For triolein hydrolysis, a measured amount of [
3
H]triolein 
(500 000 dpm/assay) in chloroform was dried under a 
stream of nitrogen and then resuspended in 10 mM Tris-
HCl (pH 7.5) buffer containing 1% gum Arabic (w/v). The 
emulsion was sonicated and converted into unilamellar 
membranes by extrusion through 0.1 µm polycarbonate 
fi lters. For the mixed micelle preparation, dried lipids, 
i. e. [
14
C] phosphatidylcholine (220 000 dpm/assay), 
[
3
H] phosphatidylcholine (250 000 dpm/assay) and 
[
32
P]phospholipids (110 000 cpm/assay) were resuspended 
in the assay buffer containing 10 mM CHAPS. The mixture 
was sonicated until a clear solution was obtained. 
2.9 Lipase assay
Release of fatty acids and the corresponding products 
(monoacylglycerol and DAG) were monitored using 
[
3
H]triolein. Assay was done in a total volume of 100 µl 
in 10 mM Tris-HCl, pH 7.5. The mixture was incubated at 
30°C for 20 min and stopped by the addition of 50 µl of 6 N
HCl before the addition of 400 µl of CHCl
3
:CH
3
OH (1:
2, v/v). The organic chloroform phase was dried (speed 
vacuum dryer), lipids were resuspended in a small volume 
of chloroform and the lipids resolved on thin-layer silica gel 
plates using petroleum ether:diethyl ether:acetic acid, (70:
30:1, v/v). After the run, the lipids were visualized on TLC 
either by autoradiography or with iodine vapour, and spots 
corresponding to the unreacted substrate and products were 
scraped off and quantifi ed with a liquid scintillation counter. 
Scintillation fl uid consisted of 0.5% toluene-2,5-diphenylox-
azole (PPO) and 0.05% 1,4-bis[2-(5-phenyloxazolyl)] 
benzene (POPOP) in toluene (w/v). Control incubations 
were carried out for zero time or in the absence of enzyme. 
The control value was subtracted from the actual assay value 
and the specifi c activity (nmol of product formed/min/mg 
protein) was calculated after the correction.
2.10 Phospholipase C assay
Enzyme activity was assayed by measuring the formation 
of DAG from phophatidylcholine in the
 
presence of CaCl
2
. 
The reaction mixture contained
 
50 mM Tris-HCl, pH 7.5, 5 
mM CaCl
2
, 1 mM PC (220 000–250 000 dpm/assay), 1 mM 
CHAPS and the enzyme source (5 µg), in a total volume of 
100 µl. The reaction was initiated by the addition of enzyme 
and it was terminated after 20 min. Lipids were separated by 
a silica–TLC
 
plate using petroleum ether:diethyl ether:acetic 
acid (70:30:1, v/v) as the solvent system. The radioactivity 
in DAG was identifi ed using a Phosphor-Imager (Amersham 
Biosciences, Molecular Dynamics). The spots of DAGs 
(1,2-, and 1,3-DAGs) were scraped off from the silica–TLC 
for the determination of radioactivity by liquid scintillation 
counting. Phospholipase C from Bacillus cereus was used 
as a positive control in time course experiments. Control 
incubations were carried out for zero time or in the absence 
of enzyme. The control values were subtracted from the 
actual assay value and the enzyme activity was calculated 
after correction. Specifi c activity was calculated using 
220–250 dpm/nmol of DAG formed and it was expressed as 
nmol of DAG formed/min/mg protein.
2.11 Study population
The study population (n = 211) comprised patients with TB 
reporting to the National Jalma Institute of Leprosy and 
other Mycobacterial Diseases in Agra, India. The patient 
population was categorized into different clinical groups, as 
per the guidelines of the National TB Control Programme, 
Central TB division, Government of India: (i) group 1 (n = 
94) patients who were diagnosed to have pulmonary TB for 
the fi rst time and had no history of taking chemotherapy; 
(ii) group 2 (n = 30) patients who had relapsed; (iii) group 
3 (n = 31) patients who had extrapulmonary TB infection. 
Pulmonary TB was confi rmed in patients belonging to 
groups 1 and 2 by the presence of acid-fast bacilli in at 
least two initial sputum smear examinations and growth of 
tubercle bacilli in BACTEC cultures. Patients with active 
TB were also examined for radiological abnormalities by 
chest X-ray. Patients in group 3 primarily had abdominal 
TB and TB meningitis. The diagnosis of extrapulmonary 
TB was carried out by histological examination as well 
as culture positivity of the bacillus in specimens obtained 
from extrapulmonary sites. Samples were obtained from all 
patients at entry into the study and those from HIV-positive 
subjects were excluded. The healthy controls included 
in the study were recruited after radiological and clinical 
examination to rule out the presence of active TB. Those 
included in the study gave written consent and the study was 
carried out after approval from the Institutional Bioethics 
Committee.
2.12 Serological characterization of Rv3847
Enzyme-linked immunosorbent assay (ELISA) was carried 
out in 96-well microtitre plates (Nunc, USA) with the 
above-mentioned recombinant PE proteins. The plates 
were incubated overnight at 4°C
 
with recombinant Rv3487c 
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Figure 1. Cloning, expression, purifi cation and generation of polyclonal antibodies of Rv3487c. (a) The Rv3487c gene was PCR 
amplifi ed with gene-specifi c primers from an M. tuberculosis BAC clone and cloned into E. coli expression vector pRSET A. Recombinant 
histidine–fl ag-tagged Rv3487c protein was expressed and purifi ed by a nickel–nitrilotriacetic acid–agarose column. Lane 1, protein marker; 
lane 2, uninduced; lane 3, induced; lane 4, purifi ed Rv3487c protein. (b) Immunoblot analysis of the samples described in (a) with Rv3487c 
rabbit polyclonal antiserum. Lane 1, induced; lane 2, uninduced; lane 3, purifi ed Rv3487c protein.
protein (1.25 µg/ml) followed by three washes with PBS–
Tween 20 (0.05%) buffer. After blocking with 3% bovine 
serum albumin (BSA) in PBS, wells were incubated with 
human sera (1:400 dilution in blocking buffer) for 1 h at 
37°C followed by washing with PBS–Tween 20 buffer. The 
above-mentioned sera dilution was selected after carrying 
out careful titration experiments with different dilutions of 
the patients’ sera. The plates were further incubated with 
anti-human IgG or anti-human IgM–horseradish peroxidase 
(HRP) followed by developing with o-phenylenediamine 
tetrahydrochloride. The absorbance values were measured at 
492 nm in an ELISA reader (Molecular Devices, USA).
2.13 Statistical analysis
Student t test was used for the analysis of statistical 
signifi cance (P value). The data on serological reactivity 
of different categories of patients were compared with the 
data from healthy controls. Graphpad Quickcalcs (online 
t test calculator [http://www.graphpad.com/quickcalcs/
ttest1.cfm]) was used for this purpose. Only P values <0.05 
were considered signifi cant. 
3. Results
3.1 Cloning, expression and purifi cation of Rv3487c
The recombinant Rv3487c was cloned, expressed and 
purifi ed as described in Materials and methods. Figure 1a 
shows the expression of histidine – fl ag-tagged Rv3487c 
protein (lane 3) and purifi cation using nickel–nitrilotriacetic 
acid agarose (Qiagen) chromatography (lane 4). The 
purifi ed Rv3487c protein was used to immunize eight-
week-old rabbits to generate polyclonal antibodies. Figure 
1b demonstrates the specifi c recognition of Rv3487c by 
polyclonal antibodies in lysates of IPTG-induced, but not 
in -uninduced, Escherichia coli BL21(DE3)/pLysS cultures 
carrying pRSET A–Rv3487c (lanes 1–2). 
3.2 Rv3487c exhibits phospholipase C-like activity
Rv3487c protein has already been shown to have carboxy 
esterase activity and annotated to be a probable lipase F 
(Zhang et al 2005). On the other hand, the same protein 
was shown to possess no lipase activity (Deb et al 2006). 
Initial experiments were carried out with radiolabelled 
triolein to assess the catalytic property of the protein, and it 
was found that the purifi ed recombinant enzyme had a very 
weak long chain with triacylglycerol acyl hydrolase activity. 
We then looked for the hydrolysis of various phospholipids 
and found that there was a marked reduction of 
32
P-labelled 
phospholipids (fi gure 2). These data suggested that Rv3487c 
protein possessed phospholipase activity and weak or no 
triacylglycerol acyl hydrolase activity. To fi nd out the type 
of phospholipase, we assessed the recombinant protein for 
the hydrolysis of [
14
C]phosphatidylcholine and analysed the 
hydrolysed products on silica–TLC. As seen in the Phosphor 
Imager (fi gure 3a), there was a time-dependent formation of 
DAGs (1,2-, and 1,3-DAGs) and a corresponding decrease 
in phosphatidylcholine (origin). These data suggested that 
the purifi ed recombinant Rv3487c protein hydrolysed the 
phosphatidylcholine into phosphocholine and DAG. When 
[
3
H]phosphatidylcholine was incubated with the recombinant 
Rv3487c enzyme there was a time- (fi gure 3b) and protein 
amount-dependent phospholipase C type of activity (fi gure 
3c). Commercially available phospholipase C was used 
as a positive control using [
3
H]phosphatidylcholine as the 
substrate (data not shown). However, we are aware that 
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Figure 2. Hydrolysis of [32P]phospholipids by the purifi ed 
recombinant Rv3487c. Phospholipid hydrolysis was conducted 
by incubating 2 mM [
32
P]phospholipid in the presence of 5.0 µg 
of recombinant Rv3487c protein at different time points, followed 
by extraction of lipid. Lipid was resolved on silica–thin-layer 
chromatography (TLC) using chloroform:methanol:acetone:acetic 
acid:water (170:25:25:25:4, v/v) as the solvent system followed by 
autoradiography. The TLC experiments were performed twice and 
a typical autoradiograph is shown. Lane 1 represents no enzyme 
control; lanes 2–6 correspond to 5, 10, 15, 20 and 30 min reaction 
time, respectively. PC, phosphatidylcholine; PE, phosphatidyl-
ethanolamine; PA, phosphatidic acid.
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comparing the phospholipase C activity of Rv3487c with a 
heterologous source to understand the relative activity may 
not be appropriate. Further, acid-treated (chemical treatment) 
or heat-killed enzyme was used as a control, which did not 
demonstrate phospholipase C activity (data not shown). 
Taken together, these fi ndings indicate that Rv3487c protein 
has phospholipase C activity.
3.3 Subcellular localization of Rv3487c
Even though most bacterial phospholipases are secretory 
proteins, M. tuberculosis phospholipase C (plcA, plcB, 
plcC) is shown to be associated with the cell wall fraction of 
M. tuberculosis (Raynaud et al 2002). In order to elucidate 
the subcellular localization of the enzyme, Rv3487c was 
subcloned into the pJAM2 vector and the pJAM2–Rv3487c 
construct was electroporated into a M. smegmatis mc2155 
strain. In this regard, bioinformatics analysis was carried out 
to explore whether M. smegmatis possesses Rv3487c and 
the results suggested that M. smegmatis does not have any 
homologous gene/s with a signifi cant identity or similarity 
in nucleotide sequence level to Rv3487c. The recombinant 
M. smegmatis expressing Rv3487c was induced with 2% 
acetamide for 24 h at 37°C and different cellular fractions 
Figure 3. Formation of diacylglycerol (DAG) from phosphatidylcholine by Rv3487c. (a) Phosphatidylcholine  hydrolysis was conducted 
by incubating 1 mM [
14
C] phosphatidylcholine (220 dpm/nmol) in the presence of 5.0 µg of the purifi ed recombinant Rv3487c protein at 
different time points, followed by lipid extraction. Lipid was resolved on silica–thin-layer chromatography (TLC) using a petroleum ether:
diethyl ether:acetic acid (70:30:1, v/v) solvent system followed by imaging by Phosphor imaging system. The TLC experiments were 
performed three times and a typical PhosphorImage is shown. Lane 1 represents no enzyme control; lanes 2–4 correspond to 5, 10 and 20 
min reaction time, respectively. FFA, free fatty acid; 1,2-DAG, 1,2-diacylglycerol; 1,3-DAG, 1,3-diacylglycerol; PC, phosphatidylcholine. 
(b) Formation of diacylglycerol from [14C]PC was carried out with 5.0 µg protein at various time points. (c) Effect of increasing amounts of 
protein was seen at 30°C for 20 min. Values are mean ± SD of four independent experiments, each performed in duplicate.
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were isolated as described earlier (Lee et al 1992; Parish 
and Stroker 1998). Western blot analysis of these cellular 
fractions was performed to identify the cellular localization 
of Rv3487c. Different cellular fractions of virulent M. 
tuberculosis (kind gift from TB research materials and 
vaccine testing contract, Colorado State University, USA) 
were also subjected to immunoblotting with polyclonal 
antibody to Rv3487c. Figure 4a demonstrates that Rv3487c 
protein is detected in whole cell lysates and cell wall 
fractions (lanes 1 and 2) of M. tuberculosis, but not in 
culture fi ltrate proteins. Additionally, subcellular fractions 
isolated from recombinant M. smegmatis expressing 
Rv3487c (fi gure 4b, lane 4) suggest that it is associated with 
the cell wall. The absence of reactivity of the anti-Rv3487c 
antibody to subcellular fractions of the vector-transformed 
M. smegmatis (fi gure 4) clearly suggests that a homologue 
of Rv3487c might be absent in M. smegmatis. 
3.4 Rv3847c elicits differential B cell responses during 
TB infection
The above-mentioned results clearly suggest that Rv3487c 
is localized to the mycobacterial cell wall leading to the 
possibility that the Rv3487c protein may be accessible 
to the immune system of infected individuals. In order to 
ascertain whether LipF protein is expressed in vivo during 
active infection with M. tuberculosis and that Rv3487c 
is immunogenic, we assessed the immunoreactivity of 
Rv3487c with sera derived from different clinical categories 
of TB patients. Humoral immune responses of group 1 
patients (those reporting symptoms of pulmonary TB for 
the fi rst time) to recombinant Rv3847c protein and 19 
kDa antigens were evaluated along with those of healthy 
controls as shown in fi gure 5a–d. In the case of children with 
pulmonary TB in group 1, Rv3487c (P=0.02, fi gure 5a) and 
19 kDa antigen (P=0.0174, fi gure 5c) showed statistically 
signifi cant IgG (fi gure 5) but not IgM immunoreactivity 
(data not shown). However, in the case of adult group 
1 patients, neither Rv3487c nor 19 kDa antigen elicited 
signifi cant IgG antibody reactivity (P>0.05) (fi gure 5a–c). 
Furthermore, sera derived from group 2 adult patients with 
relapse did not demonstrate statistically signifi cant IgG 
or IgM reactivity to Rv3487c (data not shown) and sera 
from children in group 2 were not available for our study. 
In our study, neither Rv3487c nor 19 kDa antigen elicited 
IgM reactivity in sera derived from all the three categories 
of patients (data not shown). The culture fi ltrate 19 kDa 
antigen was used in the current study as a positive control, as 
it is known to elicit strong humoral as well as cell-mediated 
host immune responses (Harris et al 1991; Faith et al 1991; 
Lyaschchenko et al 1998). 
In the case of group 3 patients (extrapulmonary 
TB), children but not adults elicited signifi cant IgG 
immunoreactivity to Rv3487c (P=0.004, fi gure 5b) and 
19 kDa antigen (P=0.008, fi gure 5d). In order to compare 
the serological sensitivities (IgG) of Rv3487c and 19 kDa, 
the data represented in fi gure 5 were recalculated as the 
percentage of individuals showing ELISA absorbance 
values above mean ± 2 SEM over values of healthy controls. 
Among all patients, Rv3487c mounted strong IgG antibody 
responses in 57% of children in group 1 and 66% of group 3 
individuals, while 19 kDa antigen elicited a response in 56% 
of children in group 1 and 63% of children in group 3. The 
observed specifi c humoral reactivity of sera from children 
Figure 4. Subcellular localization of M. tuberculosis Rv3487c and construction of recombinant M. smegmatis expressing Rv3487c. 
Different cellular fractions of virulent M. tuberculosis were probed with anti-Rv3487c polyclonal antibodies to delineate the localization 
of Rv3487c. (a) Lane 1, whole cell lysate of M. tuberculosis (WCL); lane 2, cell wall of M. tuberculosis (CW); Lane 3, culture fi ltrate 
proteins (CFP) of M. tuberculosis; Lane 4, cytosol; Lane 5 represents purifi ed Rv3487c protein. For further confi rmation, recombinant M. 
smegmatis expressing Rv3487c was constructed with an acetamide-inducible promoter and different cellular fractions were immunoblotted 
with antiserum to Rv3487c. (b) Lane 1, whole cell lysate of induced; Lane 2, whole cell lysate of uninduced; Lane 3, cytosol of induced; 
Lane 4, cell wall of induced M. smegmatis harbouring Rv3487c and Lane 5 represents purifi ed Rv3487c protein. 
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with TB in groups 1 and 3 to Rv3487c, and the relative lack 
of reactivity to sera derived from adult patients suggest the 
likelihood of a stage-specifi c expression of Rv3487c.
4. Discussion
Phospholipase genes are induced during infection of 
human THP-1 derived macrophages with M. tuberculosis. 
Phospholipase activity is higher in mycobacteria grown 
in mice than in those grown in lipid-free Dubos medium 
(Wheeler and Ratledge 1992). The vaccine strain M. bovis 
BCG and virulent M. bovis have only plcD as the plcABC 
locus is absent and plcD is suggested to account for the 
phospholipase C activity detected in M. bovis and M. bovis 
BCG (Gordon et al 1999). Rv3487c is encoded by M. bovis 
and M. bovis BCG. Our results suggest the possibility 
that Rv3487c, in addition to plcD, can account for the 
phospholipase C activity detected in M. bovis and M. bovis 
BCG. The enzymatic formation of DAG shown in fi gure 3b,c 
clearly represents an important event in the pathogenesis of 
M. tuberculosis as DAG can act as an important signalling 
molecule in infected macrophages as well as a precursor for 
synthesis of triacylglycerol, which acts as an energy store 
for utilization during long-term dormancy of M. tuberculosis 
(Daniel et al 2004). 
It has been reported that Rv3487c (LipF) posses carboxy-
esterase activity on p-nitrophenyl esters containing a short 
fatty acyl chain (Zhang et al 2005). However, a recent 
study reported that Rv3487c (LipF) did not exhibit long-
chain triacylglycerol (triolein) hydrolysis (Deb et al 2006). 
Consistent with this later study, we also failed to observe 
long-chain triacylglycerol hydrolysis (data not shown). 
Taken together, these results suggest that the esterase 
activity of Rv3487c is limited to shorter chain substrates. 
In this respect, Rv3487c exhibits multiple lipase properties 
Figure 5. Differential humoral reactivity of Rv3487c antigen with sera derived from different clinical categories of tuberculosis patients. 
(a–b) Rv3487c elicits a strong and differential antibody response in sera derived from M. tuberculosis-infected children, but not in adult 
patients or in healthy controls (HC). Rv3487c exhibited strong, statistically signifi cant reactivity to only IgG, but not to IgM (P>0.5) 
antibodies in the case of children with tuberculosis  reporting symptoms for the fi rst time (group 1, P = 0.02, a) or extrapulmonary infections 
(group 3, P = 0.004, b). (c, d) 19 kDa antigen exhibits immunoreactivity to sera derived from children in groups 1 and 3, but not to adult 
patients.
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such as carboxyesterase and phospholipase C activity. This 
phospholipase C activity represents a different class of 
activity for Rv3487c, which has not been attributed to it 
earlier. 
In addition to phospholipase C activity, immunoreactivity 
of Rv3487c with the sera of TB patients as shown in fi gure 
5 clearly suggests its expression during infection. Rv3487c 
mounted specifi c and signifi cant humoral immunoreactivity 
with sera from children in groups 1 and 3, but not with sera 
derived from adult patients; this suggests the likelihood of 
stage-specifi c expression of Rv3487c. These children either 
had symptoms of TB for the fi rst time (group 1) or had 
extrapulmonary infection (group 3) with M. tuberculosis. 
Despite marked elevation of total serum lipids in TB 
patients, serum phospholipids decrease in concentration 
in the majority of patients with active pulmonary TB as 
well as in experimental TB in guinea pigs (Beisel and 
Fiser 1970). Based on these observations, it possible that 
Rv3487c expressed during TB infection might utilize serum 
phospholipids with its phopsholipase C activity to provide 
M. tuberculosis with host fatty acids during infection. 
However, the precise signifi cance of Rv3487c expression 
in children, but not in adult TB patients, is not very clear. 
Further, possible reasons for the increased reactivity of 
Rv3487c in sera from healthy controls between paediatric 
and adult populations than in the case of patients from the 
two cohorts are not clear. Clinical stage-specifi c expression 
of Rv3487c during infection might have implications for 
serodiagnosis. Overall, selective expression of Rv3487c 
might have an important role to play in the virulence of M. 
tuberculosis. 
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